The estimated Net Worth of Pushkal Garg is at least $6.56 Milion dollars as of 24 June 2024. Pushkal Garg owns over 2,103 units of SQZ Biotechnologies Co stock worth over $6,955 and over the last 4 years Pushkal sold SQZ stock worth over $6,549,585.
Sign up
Pushkal Garg SQZ stock SEC Form 4 insiders trading
Pushkal has made over 6 trades of the SQZ Biotechnologies Co stock since 2023, according to the Form 4 filled with the SEC. Most recently Pushkal sold 2,103 units of SQZ stock worth $485,772 on 24 June 2024.
The largest trade Pushkal's ever made was selling 18,072 units of SQZ Biotechnologies Co stock on 3 March 2023 worth over $3,614,400. On average, Pushkal trades about 2,522 units every 34 days since 2020. As of 24 June 2024 Pushkal still owns at least 15,609 units of SQZ Biotechnologies Co stock.
You can see the complete history of Pushkal Garg stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Pushkal Garg's mailing address?
Pushkal's mailing address filed with the SEC is 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142.
Insiders trading at SQZ Biotechnologies Co
Over the last 4 years, insiders at SQZ Biotechnologies Co have traded over $3,939 worth of SQZ Biotechnologies Co stock and bought 2,233,026 units worth $35,530,795 . The most active insiders traders include Holdings (Private) Ltd Temasek, Public Equities, L.P.Minne ... a Amy W Schulman. On average, SQZ Biotechnologies Co executives and independent directors trade stock every 50 days with the average trade being worth of $78,593. The most recent stock trade was executed by Richard Capasso on 15 August 2022, trading 1,183 units of SQZ stock currently worth $3,939.
What does SQZ Biotechnologies Co's logo look like?
Complete history of Pushkal Garg stock trades at Alnylam Pharmaceuticals Inc a SQZ Biotechnologies Co
SQZ Biotechnologies Co executives and stock owners
SQZ Biotechnologies Co executives and other stock owners filed with the SEC include:
-
Dr. Armon R. Sharei Ph.D.,
Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director -
Teri Loxam,
Consultant & Advisor -
Dr. Howard Bernstein M.D., Ph.D.,
Chief Scientific Officer -
Lawrence J. Knopf,
Gen. Counsel & Sec. -
Micah Zajic,
Chief Bus. Officer -
Ipsita Roymoulik Ph.D.,
Sr. VP of CMC & QUALITY -
Dr. Marshelle Smith Warren M.D.,
Chief Medical Officer -
David First,
Chief People Officer -
Dr. Howard Bernstein,
Chief Scientific Officer -
Richard V. Capasso CPA,
Chief Accounting Officer -
Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
Co-Founder & Member of Scientific Advisory Board -
Micah Zajic,
Chief Financial Officer -
Howard Phd Md Bernstein,
Interim Chief Executive Office -
Holdings (Private) Ltd Temasek,
10% owner -
Oliver Rosen,
Chief Medical Officer -
Paul Bolno,
Director -
Sapna Srivastava,
Director -
Teri Loxam,
Chief Financial Officer -
Pushkal Garg,
Director -
Klavs F. Jensen,
Director -
International Group, Inc. A...,
10% owner -
Marc Elia,
Director -
David First,
Chief People Officer -
Armon Sharei,
President and CEO -
Amy W Schulman,
Director -
Marc Schegerin,
Director -
Lawrence J Knopf,
General Counsel -
Eric Moessinger,
Director -
Schulman, As Trustee The Ar...,
10% owner -
Public Equities, L.P.Minne ...,
-
Management Co. Vii, L.L.C.P...,
-
Bernard Coulie,
Director -
Patrick V.J.J. Vink,
Director -
Richard Capasso,
See Remarks -
Marshelle Smith Warren,
Chief Medical Officer